CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Anixa Biosciences, Inc. - ANIX CFD

    2.99
    0.67%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.23
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 2.97
    Open* 2.94
    1-Year Change* -1.67%
    Day's Range* 2.9 - 3.04
    52 wk Range 2.50-6.25
    Average Volume (10 days) 61.46K
    Average Volume (3 months) 1.10M
    Market Cap 143.80M
    P/E Ratio -100.00K
    Shares Outstanding 30.92M
    Revenue N/A
    EPS -0.40
    Dividend (Yield %) N/A
    Beta 0.96
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 29, 2022 2.99 0.05 1.70% 2.94 3.08 2.90
    Jun 28, 2022 2.97 -0.04 -1.33% 3.01 3.14 2.95
    Jun 27, 2022 3.16 0.15 4.98% 3.01 3.19 3.01
    Jun 24, 2022 3.04 0.07 2.36% 2.97 3.12 2.97
    Jun 23, 2022 3.13 0.11 3.64% 3.02 3.19 3.02
    Jun 22, 2022 3.18 0.21 7.07% 2.97 3.18 2.97
    Jun 21, 2022 3.08 0.06 1.99% 3.02 3.19 3.02
    Jun 17, 2022 3.00 -0.16 -5.06% 3.16 3.16 2.96
    Jun 16, 2022 3.10 0.15 5.08% 2.95 3.18 2.90
    Jun 15, 2022 3.08 0.29 10.39% 2.79 3.15 2.79
    Jun 14, 2022 2.88 -0.18 -5.88% 3.06 3.09 2.82
    Jun 13, 2022 3.07 -0.18 -5.54% 3.25 3.31 3.04
    Jun 10, 2022 3.33 -0.10 -2.92% 3.43 3.48 3.27
    Jun 9, 2022 3.48 0.07 2.05% 3.41 3.68 3.41
    Jun 8, 2022 3.50 0.23 7.03% 3.27 3.54 3.27
    Jun 7, 2022 3.38 -0.49 -12.66% 3.87 3.91 3.30
    Jun 6, 2022 3.92 -0.27 -6.44% 4.19 4.44 3.87
    Jun 3, 2022 3.94 0.16 4.23% 3.78 3.96 3.61
    Jun 2, 2022 3.81 0.01 0.26% 3.80 3.85 3.74
    Jun 1, 2022 3.69 0.18 5.13% 3.51 3.70 3.37

    Anixa Biosciences, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0.5125 0 0.25 1.1125
    Revenue 0 0.5125 0 0.25 1.1125
    Total Operating Expense 13.875 13.6482 9.9782 12.14 15.4016
    Selling/General/Admin. Expenses, Total 7.172 7.0735 5.597 5.66283 6.91183
    Research & Development 6.703 6.18969 4.38121 5.47343 6.81304
    Depreciation / Amortization 0 0.41875 0.3253
    Unusual Expense (Income) 0 0.385 0 0.585 1.35139
    Other Operating Expenses, Total
    Operating Income -13.875 -13.1357 -9.9782 -11.89 -14.2891
    Interest Income (Expense), Net Non-Operating 0.104 0.00232 0.03392 0.07135 0.04597
    Net Income Before Taxes -13.771 -13.1279 -10.0924 -11.8187 -14.2431
    Net Income After Taxes -13.771 -13.1279 -10.0924 -11.8187 -14.2431
    Net Income Before Extra. Items -13.595 -12.9544 -10.0184 -11.647 -13.996
    Net Income -13.595 -12.9544 -10.0184 -11.647 -13.996
    Income Available to Common Excl. Extra. Items -13.595 -12.9544 -10.0184 -11.647 -13.996
    Income Available to Common Incl. Extra. Items -13.595 -12.9544 -10.0184 -11.647 -13.996
    Diluted Net Income -13.595 -12.9544 -10.0184 -11.647 -13.996
    Diluted Weighted Average Shares 30.374 28.5789 22.229 19.7898 17.6243
    Diluted EPS Excluding Extraordinary Items -0.44759 -0.45329 -0.45069 -0.58854 -0.79413
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -0.44759 -0.44 -0.44403 -0.55898 -0.71745
    Total Adjustments to Net Income 0
    Minority Interest 0.176 0.17352 0.07401 0.1716 0.24706
    Gain (Loss) on Sale of Assets 0 0.00545 -0.14808
    Jan 2023 Oct 2022 Jul 2022 Apr 2022 Jan 2022
    Total revenue 0 0 0 0 0
    Revenue 0 0 0 0 0
    Total Operating Expense 2.556 3.609 2.797 3.589 3.88
    Selling/General/Admin. Expenses, Total 1.488 1.924 1.352 1.854 2.042
    Research & Development 1.068 1.685 1.445 1.735 1.838
    Unusual Expense (Income) 0 0 0 0 0
    Operating Income -2.556 -3.609 -2.797 -3.589 -3.88
    Interest Income (Expense), Net Non-Operating 0.202 0.08 0.022 0.001 0.001
    Net Income Before Taxes -2.354 -3.529 -2.775 -3.588 -3.879
    Net Income After Taxes -2.354 -3.529 -2.775 -3.588 -3.879
    Minority Interest 0.032 0.053 0.029 0.044 0.05
    Net Income Before Extra. Items -2.322 -3.476 -2.746 -3.544 -3.829
    Net Income -2.322 -3.476 -2.746 -3.544 -3.829
    Income Available to Common Excl. Extra. Items -2.322 -3.476 -2.746 -3.544 -3.829
    Income Available to Common Incl. Extra. Items -2.322 -3.476 -2.746 -3.544 -3.829
    Diluted Net Income -2.322 -3.476 -2.746 -3.544 -3.829
    Diluted Weighted Average Shares 30.921 30.764 30.451 30.152 30.125
    Diluted EPS Excluding Extraordinary Items -0.07509 -0.11299 -0.09018 -0.11754 -0.1271
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.07509 -0.11299 -0.09018 -0.11754 -0.1271
    Gain (Loss) on Sale of Assets 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 36.0034 9.36862 6.09312 5.53837 7.01394
    Cash and Short Term Investments 35.7279 9.05706 5.84163 5.05589 6.83937
    Cash & Equivalents 29.1283 6.41706 3.49163 3.05589 3.33937
    Short Term Investments 6.5996 2.64 2.35 2 3.5
    Prepaid Expenses 0.27556 0.30933 0.18497 0.17549 0.17457
    Total Assets 36.2574 9.45296 6.29369 6.44854 8.81242
    Property/Plant/Equipment, Total - Net 0.25396 0.05434 0.20057 0.07267 0.0527
    Property/Plant/Equipment, Total - Gross 0 0.29558 0.12647 0.08843
    Accumulated Depreciation, Total 0 -0.09502 -0.0538 -0.03573
    Intangibles, Net 0 0.8375 1.74578
    Total Current Liabilities 1.27053 1.18859 1.48132 1.26511 0.88949
    Accounts Payable 0.1362 0.23237 0.58582 0.58201 0.48032
    Accrued Expenses 1.13433 0.95622 0.8955 0.6831 0.40917
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total
    Total Liabilities 0.8201 0.69161 1.05834 1.01373 0.88949
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0.22008 0
    Total Equity 35.4373 8.76136 5.23535 5.43481 7.92292
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.30051 0.24249 0.20332 0.18909 0.16603
    Additional Paid-In Capital 239.927 200.354 186.849 175.416 163.931
    Retained Earnings (Accumulated Deficit) -204.79 -191.836 -181.817 -170.17 -156.174
    Total Liabilities & Shareholders’ Equity 36.2574 9.45296 6.29369 6.44854 8.81242
    Total Common Shares Outstanding 30.0509 24.2487 20.3318 18.9086 16.6028
    Total Preferred Shares Outstanding 0 0 0 0 0
    Total Receivables, Net 0.00223 0.06653 0.30699
    Accounts Receivable - Trade, Net 0.00223 0.06653 0.30699
    Minority Interest -0.67051 -0.49698 -0.42298 -0.25138
    Other Long Term Assets, Total 0 0.03
    Apr 2022 Jan 2022 Oct 2021 Jul 2021 Apr 2021
    Total Current Assets 32.563 34.994 36.0034 37.052 38.472
    Cash and Short Term Investments 32.231 34.53 35.7279 36.622 38.1027
    Cash & Equivalents 27.732 29.781 29.1283 27.2222 27.7034
    Short Term Investments 4.499 4.749 6.5996 9.39978 10.3993
    Prepaid Expenses 0.332 0.464 0.27556 0.43001 0.36921
    Total Assets 32.797 35.238 36.2574 37.0624 38.4975
    Property/Plant/Equipment, Total - Net 0.234 0.244 0.25396 0.01041 0.02557
    Other Long Term Assets, Total 0 0 0
    Total Current Liabilities 1.189 1.787 1.27053 1.20802 1.44287
    Accounts Payable 0.093 0.504 0.1362 0.20773 0.43801
    Accrued Expenses 1.096 1.283 1.13433 1.00029 1.00486
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 0.626 1.275 0.8201 0.5953 0.88376
    Total Long Term Debt 0 0 0 0 0
    Minority Interest -0.765 -0.721 -0.67051 -0.61273 -0.55911
    Total Equity 32.171 33.963 35.4373 36.4671 37.6138
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.302 0.301 0.30051 0.2995 0.3145
    Additional Paid-In Capital 244.032 242.281 239.927 236.944 233.742
    Retained Earnings (Accumulated Deficit) -212.163 -208.619 -204.79 -200.777 -196.443
    Total Liabilities & Shareholders’ Equity 32.797 35.238 36.2574 37.0624 38.4975
    Total Common Shares Outstanding 30.1547 30.1323 30.0509 29.9499 31.4499
    Other Liabilities, Total 0.202 0.209 0.22008
    Total Preferred Shares Outstanding 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -13.1279 -10.0924 -11.8187 -14.2431 -5.00899
    Cash From Operating Activities -4.93688 -6.17567 -4.74143 -4.2734 -3.79671
    Cash From Operating Activities 0 0.03828 0.04756 0.01844 0.04322
    Amortization 0 0.41875 0.3253 0.3253
    Non-Cash Items 8.1125 4.33743 6.1325 9.55825 0.43553
    Changes in Working Capital 0.07855 -0.45901 0.47842 0.0677 0.40824
    Cash From Investing Activities -3.91768 -0.30579 -0.52546 1.4616 -2.73519
    Capital Expenditures 0 -0.01579 -0.17546 -0.0384 -0.03019
    Other Investing Cash Flow Items, Total -3.91768 -0.29 -0.35 1.5 -2.705
    Cash From Financing Activities 31.5658 9.4069 5.70262 2.52832 7.38295
    Financing Cash Flow Items 0.01403 0
    Issuance (Retirement) of Stock, Net 31.5658 9.4069 5.68858 2.52832 10.3829
    Net Change in Cash 22.7112 2.92544 0.43574 -0.28348 0.85105
    Cash Interest Paid 0.00182 0.03989 0 0.27243
    Issuance (Retirement) of Debt, Net 0 -3
    Apr 2022 Jan 2022 Oct 2021 Jul 2021 Apr 2021
    Net income/Starting Line -7.467 -3.879 -13.1279 -9.05688 -4.66927
    Cash From Operating Activities -3.503 -1.197 -4.93688 -3.89271 -2.41195
    Cash From Operating Activities 0 0 0
    Non-Cash Items 4.12 2.364 8.1125 5.26318 2.06069
    Cash Interest Paid 2 1 0.00182 0.00168 0.0014
    Changes in Working Capital -0.156 0.318 0.07855 -0.09901 0.19663
    Cash From Investing Activities 2.1 1.85 -3.91768 -6.72434 -7.72385
    Capital Expenditures 0 0 0
    Other Investing Cash Flow Items, Total 2.1 1.85 -3.91768 -6.72434 -7.72385
    Cash From Financing Activities 0.007 0 31.5658 31.4222 31.4222
    Financing Cash Flow Items 0 -2.54893 -2.54893
    Issuance (Retirement) of Stock, Net 0.007 0 31.5658 33.9711 33.9711
    Net Change in Cash -1.396 0.653 22.7112 20.8051 21.2864
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.2268 1307142 7144 2022-12-31 LOW
    Titterton (Lewis H Jr) Individual Investor 2.5031 774070 0 2023-01-17 LOW
    UBS Financial Services, Inc. Investment Advisor 2.0131 622544 853 2022-12-31 LOW
    Kumar (Amit) Individual Investor 1.4943 462100 0 2023-01-17 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9353 289238 -2985 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.887 274289 3626 2022-12-31 LOW
    Long Focus Capital Management LLC Hedge Fund 0.5358 165701 0 2022-12-31 MED
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3302 102100 0 2022-12-31 LOW
    Baskies (Arnold M) Individual Investor 0.3234 100000 0 2023-01-17 LOW
    Susquehanna International Group, LLP Investment Advisor 0.2297 71023 31115 2022-12-31 MED
    Raymond James & Associates, Inc. Research Firm 0.185 57217 -3629 2022-12-31 LOW
    Newton Investment Management North America, LLC Investment Advisor 0.179 55350 0 2022-12-31 MED
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1777 54948 0 2022-12-31 LOW
    Morgan Stanley Smith Barney LLC Investment Advisor 0.1582 48925 -714 2022-12-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.1549 47900 -9300 2022-12-31 HIGH
    Citadel Advisors LLC Hedge Fund 0.1536 47506 27896 2022-12-31 HIGH
    Gottschalk (Emily) Individual Investor 0.1477 45665 0 2023-01-17 LOW
    BNY Mellon Asset Management Investment Advisor 0.1367 42268 -238 2022-12-31 LOW
    Cambridge Investment Research Advisors, Inc. Investment Advisor 0.1297 40100 25100 2022-12-31 LOW
    Corecap Advisors Inc Investment Advisor/Hedge Fund 0.1171 36209 -1177 2022-12-31 MED

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    3150 Almaden Expy Ste 250
    95118

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Biaya inap posisi Long -0.4092%
    Biaya inap posisi short 0.3873%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.005

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Biaya inap posisi Long -0.0249%
    Biaya inap posisi short 0.0027%
    Waktu biaya inap 21:00 (UTC)
    Spread 3.0

    BTC/USD

    28,639.05 Price
    +0.760% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda